Overview

Study of HD Mesh Ablation System for Treatment of Paroxysmal Atrial Fibrillation

Status:
Terminated
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
This is a randomized controlled study of the Bard High Density Mesh Ablation System for treatment of paroxysmal atrial fibrillation. This study will determine if the HD Mesh Ablation System is as safe as and more effective than anti-arrhythmic drugs.
Phase:
Phase 3
Details
Lead Sponsor:
C. R. Bard
Treatments:
Anti-Arrhythmia Agents